Invalid Symbol

Stock Research for EVOK

EVOK
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

EVOK Stock Chart & Research Data

The EVOK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EVOK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EVOK Due diligence Resources & Stock Charts

The EVOK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EVOK Detailed Price Forecast - CNN Money CNN View EVOK Detailed Summary - Google Finance
Yahoo View EVOK Detailed Summary - Yahoo! Finance Zacks View EVOK Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View EVOK Trends & Analysis - Trade-Ideas Barrons View EVOK Major Holders - Barrons
NASDAQ View EVOK Call Transcripts - NASDAQ Seeking View EVOK Breaking News & Analysis - Seeking Alpha
Spotlight View EVOK Annual Report - CompanySpotlight.com OTC Report View EVOK OTC Short Report - OTCShortReport.com
TradeKing View EVOK Fundamentals - TradeKing Charts View EVOK SEC Filings - Bar Chart
WSJ View Historical Prices for EVOK - The WSJ Morningstar View Performance/Total Return for EVOK - Morningstar
MarketWatch View the Analyst Estimates for EVOK - MarketWatch CNBC View the Earnings History for EVOK - CNBC
StockMarketWatch View the EVOK Earnings - StockMarketWatch MacroAxis View EVOK Buy or Sell Recommendations - MacroAxis
Bullish View the EVOK Bullish Patterns - American Bulls Short Pains View EVOK Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View EVOK Stock Mentions - StockTwits PennyStocks View EVOK Stock Mentions - PennyStockTweets
Twitter View EVOK Stock Mentions - Twitter Invest Hub View EVOK Investment Forum News - Investor Hub
Yahoo View EVOK Stock Mentions - Yahoo! Message Board Seeking Alpha View EVOK Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for EVOK - SECform4.com Insider Cow View Insider Transactions for EVOK - Insider Cow
CNBC View EVOK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EVOK - OTC Markets
Yahoo View Insider Transactions for EVOK - Yahoo! Finance NASDAQ View Institutional Holdings for EVOK - NASDAQ


Stock Charts

FinViz View EVOK Stock Insight & Charts - FinViz.com StockCharts View EVOK Investment Charts - StockCharts.com
BarChart View EVOK Stock Overview & Charts - BarChart Trading View View EVOK User Generated Charts - Trading View


Latest Financial News for EVOK

Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti™
Posted on Thursday February 15, 2018

SOLANA BEACH, Calif., Feb. 15, 2018-- Evoke Pharma, Inc., a specialty pharmaceutical company focused on treatments for gastrointestinal d­­ iseases, today announced additional findings from its comparative ...


Wired News – Akari’s Phase-II COBALT Trial of Coversin in Patients with PNH Met the Primary Endpoint
Posted on Tuesday December 12, 2017

Stock Monitor: Evoke Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 12, 2017 / Active-Investors issued a free report on Akari Therapeutics, PLC (NASDAQ: AKTX ), which is readily accessible ...


Wired News – SteadyMed Reported FDA Agreed Pathway to Trevyent NDA Resubmission
Posted on Monday December 11, 2017

Stock Monitor: Evoke Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 11, 2017 / Active-Investors issued a free report on SteadyMed Ltd (NASDAQ: STDY ), which is readily accessible upon ...


Evoke Pharma, Inc. to Host Earnings Call
Posted on Tuesday November 14, 2017

NEW YORK, NY / ACCESSWIRE / November 14, 2017 / Evoke Pharma, Inc. (EXCHANGE: EVOK ) will be discussing their earnings results in their Q3 Earnings Call to be held on Tuesday, November 14, 2017 at 4:30 ...


Evoke Pharma reveals its gastroparesis nasal spray is only effective in women
Proactive Investors UK - Feb 15, 2018
Evoke Pharma Inc (NASDAQ:EVOK) was one of the top fallers on the major US indexes after it confirmed that its Gimoti gastroparesis treatment is only effective in women.
Are Analysts Bullish Evoke Pharma, Inc. (NASDAQ:EVOK) After Last Week? - BZ Weekly

Evoke Pharma Inc.
MarketWatch - Jul 12, 2016
Evoke Pharma Inc. Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases.

Evoke Pharma Announces Positive Topline Results from Comparative Exposure ...
GlobeNewswire (press release) - Oct 23, 2017
SOLANA BEACH, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced positive topline results from the Company's ...
Evoke to submit US marketing application for Gimoti in Q1; shares ahead 14 ... - Seeking Alpha

Evoke Pharma: Hop On And Ride The Elevator Higher
Seeking Alpha - Jul 31, 2016
Evoke Pharma shares fell to a 52-week low of $1.52 after a Phase 3 trial of EVK-001 in gastroparesis in women failed to meet its primary endpoint.

Enter a stock symbol to view the stock details.